Stock Evaluator: SeaStar Medical Holding Corporation (ICU)

SeaStar Medical Holding Corporation ICU

$0.94 -0.12 -10.95%
November 20, 2026 4:00:00 PM EST November 10, 2021 Volume: 134,187
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Commentary & Analysis


Financial Summary

Share Statistics ICU Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $4.9 $363.7 5%
Shares Out (Mil) 4.4 41.1 13%
Institutional Ownership 80.1% 82.7% 48%
Float (Mil) 5.2 36.7 12%
Beta -1.04 0.89 1%
Avg Daily Volume (000s) 326 326 51%
Price Change
(52-week)
(70.4%) 54.6% 13%
Growth ICU Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 11.8% na
Net Income (5yr) (29.9%) (5.8%) 14%
EPS (5yr) na 10.6% na
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) na (15.6%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials ICU Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $2 $123 3%
Net Income (TTM) (Mil) ($15) ($9) 26%
EPS (TTM) ($3.663) ($0.300) 10%
Operating Cash Flow (TTM) (Mil) ($13) ($1) 18%
Net Cash Flow (TTM) (Mil) na $2 na
Long-Term Debt (Q1) (Mil) $0 $21 0%
Enterprise Value (Q1) (Mil) $0 $381 5%
Valuation ICU Industry
Median
Percentile
(All Stocks)
P/B 8.36 2.41 91%
P/E na 25.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.3 na
Ratios ICU Industry
Median
Percentile
(All Stocks)
Gross Margin 92.6% 59.5% 94%
Net Margin (678.2%) (5.0%) 1%
ROA (140.9%) (10.4%) 3%
ROE (246.1%) (8.4%) 3%
Liabilities to Assets 91.2% 45.8% 88%
F-Score 2 4 7%

SeaStar Medical Holding Corporation did not pass any screens on 11/20/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors